Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Correct me if I'm wrong. Its not a question of if but when.

I recall our tempory CEO saying in a letter to the shareholders that his plan was to resume the dividend payout when revenues resumed. I believe he said it would be based on 10%-20% of revs.

Share
New Message
Please login to post a reply